Clinical Trials Directory

Trials / Unknown

UnknownNCT00692809

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection

Impact of HIV Infection on Latent TB Among Patients With HIV-TB Co-infection

Status
Unknown
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Ministry of Science and Technology, India · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

HIV induced altered representation and function of regulatory T cell subsets (NKT and Treg cells) impair the protective T cell response against M.tuberculosis and disrupts LTBI, thus facilitates faster progression and development of severe forms of clinical TB in HIV-TB co-infection.

Detailed description

During the natural course of HIV disease, emergence of opportunistic infection not only imposes morbidity on HIV-TB co-infected patients, but also facilitates viral replication causing faster disease progression. Tuberculosis, being the commonest among the opportunistic infections among HIV infected persons deserves special attention. Moreover, disruption of latency of TB infection (LTBI) with development of more severe clinical forms at relatively early stage of HIV disease when CD4 count still remains above 300/ul, makes TB a unique opportunistic infection and negatively influence the outcome of dual infection.This is suggestive of impairment of some critical immune function involving relatively less frequent fine T cell subsets with functional hierarchy over bulk T cells, so as to weaken the immune containment of LTBI resulting in reactivation of M. tuberculosis and manifestation of severe forms of TB.HIV has recently been reported to preferentially infect, destroy and incapacitate two key immune-regulatory T cell subsets, namely NKT and Treg cells.Therefore, studying them along the course of HIV disease and impact of their changes on the function of effector T cells directed against M.tuberculosis is important.

Conditions

Timeline

Start date
2008-07-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2008-06-06
Last updated
2009-09-15

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT00692809. Inclusion in this directory is not an endorsement.